BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23594232)

  • 21. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
    Hsu DW; Louis DN; Efird JT; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):857-65. PubMed ID: 9258255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining.
    Terlikowski S; Sulkowski S; Lenczewski A; Musiatowicz B; Kulikowski M
    Arch Gynecol Obstet; 1999 Nov; 263(1-2):29-33. PubMed ID: 10728625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours.
    Athanassiadou P; Petrakakou E; Sakelariou V; Zerva C; Liossi A; Michalas S; Athanassiades P
    Eur J Cancer Prev; 1998 Jun; 7(3):225-31. PubMed ID: 9696931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression and relationships of HER-2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian cancer.
    Goff BA; Shy K; Greer BE; Muntz HG; Skelly M; Gown AM
    Eur J Gynaecol Oncol; 1996; 17(6):487-92. PubMed ID: 8971524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
    Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
    Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SSRI use and clinical outcomes in epithelial ovarian cancer.
    Christensen DK; Armaiz-Pena GN; Ramirez E; Matsuo K; Zimmerman B; Zand B; Shinn E; Goodheart MJ; Bender D; Thaker PH; Ahmed A; Penedo FJ; DeGeest K; Mendez L; Domann F; Sood AK; Lutgendorf SK
    Oncotarget; 2016 May; 7(22):33179-91. PubMed ID: 27121207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women.
    Licaj I; Jacobsen BK; Selmer RM; Maskarinec G; Weiderpass E; Gram IT
    Br J Cancer; 2017 Jan; 116(2):270-276. PubMed ID: 27959888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis.
    Fajac A; Benard J; Lhomme C; Rey A; Duvillard P; Rochard F; Bernaudin JF; Riou G
    Int J Cancer; 1995 Apr; 64(2):146-51. PubMed ID: 7615357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grading of ovarian carcinomas.
    Mayr D; Diebold J
    Int J Gynecol Pathol; 2000 Oct; 19(4):348-53. PubMed ID: 11109164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the adrenomedullin gene in epithelial ovarian cancer.
    Hata K; Takebayashi Y; Akiba S; Fujiwaki R; Iida K; Nakayama K; Nakayama S; Fukumoto M; Miyazaki K
    Mol Hum Reprod; 2000 Oct; 6(10):867-72. PubMed ID: 11006313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
    Ikeda J; Oda T; Inoue M; Uekita T; Sakai R; Okumura M; Aozasa K; Morii E
    Cancer Sci; 2009 Mar; 100(3):429-33. PubMed ID: 19077003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.
    Sarbia M; Bittinger F; Porschen R; Dutkowski P; Torzewski M; Willers R; Gabbert HE
    Br J Cancer; 1996 Oct; 74(7):1012-6. PubMed ID: 8855967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.
    Makar AP; Baekelandt M; Tropé CG; Kristensen GB
    Gynecol Oncol; 1995 Feb; 56(2):175-80. PubMed ID: 7896181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations.
    Semczuk A; Skomra D; Cybulski M; Jakowicki JA
    Histochem J; 2001 Apr; 33(4):193-200. PubMed ID: 11550800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
    Curling M; Stenning S; Hudson CN; Watson JV
    J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial adenocarcinoma of endometrioid subtype with squamous differentiation: an immunohistochemical study of MIB-1 (ki-67 paraffin), cathepsin D, and C-erbB-2 protein (p185).
    Nielsen AL; Nyholm HC
    Int J Gynecol Pathol; 1995 Jul; 14(3):230-4. PubMed ID: 8600074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.
    Sevelda P; Denison U; Schemper M; Spona J; Vavra N; Salzer H
    Br J Obstet Gynaecol; 1990 Aug; 97(8):706-12. PubMed ID: 2400748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
    Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
    Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
    Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
    JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival.
    Katsaros D; Yu H; Levesque MA; Danese S; Genta F; Richiardi G; Fracchioli S; Khosravi MJ; Diamandi A; Gordini G; Diamandis EP; Massobrio M
    Eur J Cancer; 2001 Mar; 37(4):478-85. PubMed ID: 11267857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.